Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 2—February 2010
Dispatch

Severe Leptospirosis in Hospitalized Patients, Guadeloupe

Cécile Herrmann-StorckComments to Author , Magalie Saint Louis, Tania Foucand, Isabelle Lamaury, Jacqueline Deloumeaux, Guy Baranton, Maurice Simonetti, Natacha Sertour, Muriel Nicolas, Jacques Salin, and Muriel Cornet
Author affiliations: Guyane University, Guadeloupe, French West Indies (C. Herrman-Storck, M. Saint Louis, T. Foucand, I. Lamaury, J. Deloumeaux, M. Simonetti, M. Nicholas, J. Salin); Institut Pasteur, Paris, France (G. Baranton, N. Serour, M. Cornet); and Paris Descartes University, Paris (M. Cornet)

Main Article

Table 2

Laboratory findings for 168 case-patients with confirmed leptospirosis, Hospital of Pointe-à-Pitre, Guadeloupe, French West Indies, 2003–2004*

Laboratory findings Univariate analysis
Multivariate analysis
All case-patients, N = 168† Case-patients with severe disease, n = 24† Case-patients with nonsevere disease, n = 144† p value
OR (95% CI) p value
Prothrombin time <70% 10/118 (8.5) 5/21 (23.8) 5/97 (5.1) 0.01 0.7 (0.05–9.8) 0.077
Thrombocytopenia, <50 × 109 cells/L 25/135 (18.5) 8/23 (34.8) 17/112 (15.2) 0.02 1 (0.1–2.4) 0.96
Hyperneutrophilia, >12 × 109 cells/L 24/136 (17.6) 10/23 (43.5) 14/113 (12.4) 0.01 0.9 (0.1–7.1) 0.93
ALT >119 U/L 30/108 (27.8) 6/23 (26.1) 24/85 (28.2) 0.8
AST >102 U/L 58/128 (45.3) 17/23 (73.9) 41/105 (39) 0.02 4.3 (1.2–14.6) 0.021
CPK >1000 U/L 22/108 (20.4) 5/18 (27.8) 17/90 (18.9) 0.4
LDH >800 U/L 11/101 (10.9) 3/17 (17.6) 8/84 (9.5) 0.3
Amylase >285 U/L 16/82 (19.5) 8/15 (53.3) 8/67 (11.9) <0.001 18.5 (3.8–88.8) <0.001
Lipase >60 U/L
7/40 (17.5)
2/8 (25)
5/32 (15.6)
0.8



Hemoglobin, g/dL 12.9 ± 0.6 (136) 11.1 ± 2.0 (23) 13.2 ± 3.4 (113) 0.01
Hemoglobin <10 g/dL
13/136 (9.5)
5/23 (21.7)
8/113 (7.1)
0.04

2.3 (0.5–9.8)
0.2
Bilirubin, mg/dL 8.3 ± 2.3 (86) 15.2 ± 11.7 (18) 5.8 ± 7.2 (68) <0.001
Bilirubin >7 mg/dL
31/86 (36.0)
13/18 (72.2)
18/68 (26.4)
<0.001

0.48 (0.05–4.7)
0.6
Potassium, mmol/L 4.0 ± 0.22 (136) 3.8±.9 (23) 4.0 ± 1.3 (113) 0.5
Sodium, mmol/L
133.5 ± 4.2 (136)
132.8 ± 5.3 (23)
133.6 ± 3.9 (113)
0.5



Creatinine, mg/d 2.0 ± 0.3 (130) 2.8 ± 2.5 (21) 1.9 ± 2.0 (109) 0.05 2.0 (0.6–6.6) 0.2
Creatinine >1.5 mg/dL
54/130 (41.5)
11/21 (52.4)
43/109 (39.4)
0.2



Urea nitrogen mg/dL
69.0 ± 10.2 (136)
85.8 ± 76.2 (23)
64.2 ± 64.2 (113)
0.5



Isolation of Leptospira in 
blood culture 55/88 (62.5) 8/14 (57.1) 47/74 (63.5) 0.3
L. interrogans serovar 
 Icterohemorrhagiae 18/40‡ (45) 6/8 (75) 12/32 (37.5) 0.06 5.3 (1.0–26.0) 0.004
L. borgpetersenii serovar 
 Castellonis 5/40‡ (12.5) 0/8 5/32 (15.6) 0.1
L. borgpetersenii serovar
 Arborea 9/40‡ (22.5) 2/8 (25) 7/32 (21.9) 0.6
L. kirschneri serovar 
 Bogvere 6/40‡ (15) 0/8 6/32 (18.7) 0.1
L. santarosai serovar 
 Tabaquite 2/40‡ (5) 0/8 2/8 (25) 0.4

*OR, odds ratio; CI, confidence interval; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatinine phosphokinase; LDH, lactate dehydrogenase. Boldface indicates significance.
†Mean ± SD (examined) or no. case-patients/no. examined (%).
‡Serovar identification was completed for 40 of the 55 Leptospira strains isolated.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external